Anesth Pain Med.  2020 Oct;15(4):466-471. 10.17085/apm.20037.

Liver transplantation in an adult patient with hepatocellular carcinoma following liver cirrhosis as a complication of the Fontan procedure -A case report-

• Cho Mk
• Kwon JH
• Gwak MS
• Joh JW
• Hwang J
• Kim GS

• KMID: 2508409
• DOI: http://doi.org/10.17085/apm.20037

Abstract

Background
Fontan-associated liver disease (FALD) is a hepatic disorder caused by hemodynamic changes and systemic venous congestion following the Fontan procedure. FALD includes liver cirrhosis and hepatocellular carcinoma (HCC), both of which may require liver transplantation (LT). However, the Fontan circulation, characterized by elevated central venous pressure and reduced cardiac output, is a challenging issue for surgeons and anesthesiologists. Case: We report a living-donor LT for the treatment of HCC. The patient was a 24-year-old male who underwent the Fontan procedure for pulmonary atresia and right ventricle hypoplasia. We focused on maintaining enough blood volume for cardiac output without causing pulmonary edema, as the patient is not well adapted to changes in volume. Owing to a multidisciplinary approach, the surgery was successfully performed without fatal adverse events.
Conclusions
To our knowledge, this is the first case of isolated LT in a recipient who became an adult after having undergone the Fontan procedure.

Keyword

Fontan-associated liver disease; Fontan procedure; Hepatocellular carcinoma; Liver transplantation

Figure

• 

  Fig. 1. Patient’s cardiac anomaly status after the Fontan operation.

Reference

1. Mazzarelli C, Cannon MD, Hudson M, Heaton N, Sarker D, Kane P, et al. Hepatocellular carcinoma as a complication of vascular disease of the liver after Fontan procedure. Hepatology. 2019; 69:911–3.

2. Téllez L, Rodríguez-Santiago E, Albillos A. Fontan-associated liver disease: a review. Ann Hepatol. 2018; 17:192–204.

3. Gordon-Walker TT, Bove K, Veldtman G. Fontan-associated liver disease: a review. J Cardiol. 2019; 74:223–32.

4. Téllez L, Rodríguez de Santiago E, Minguez B, Payance A, Clemente A, Baiges A, et al. VALDIG an EASL consortium. Prevalence, features and predictive factors of liver nodules in Fontan surgery patients: the VALDIG Fonliver prospective cohort. J Hepatol. 2020; 72:702–10.

5. Asrani SK, Asrani NS, Freese DK, Phillips SD, Warnes CA, Heimbach J, et al. Congenital heart disease and the liver. Hepatology. 2012; 56:1160–9.

6. Bang SR, Ahn HJ, Kim GS, Yang M, Gwak MS, Ko JS, et al. Predictors of high intraoperative blood loss derived by simple and objective method in adult living donor liver transplantation. Transplant Proc. 2010; 42:4148–50.

7. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012; 56:908–43.

8. Ghaferi AA, Hutchins GM. Progression of liver pathology in patients undergoing the Fontan procedure: chronic passive congestion, cardiac cirrhosis, hepatic adenoma, and hepatocellular carcinoma. J Thorac Cardiovasc Surg. 2005; 129:1348–52.

9. Asrani SK, Warnes CA, Kamath PS. Hepatocellular carcinoma after the Fontan procedure. N Engl J Med. 2013; 368:1756–7.

10. Saliba T, Dorkhom S, O'Reilly EM, Ludwig E, Gansukh B, Abou-Alfa GK. Hepatocellular carcinoma in two patients with cardiac cirrhosis. Eur J Gastroenterol Hepatol. 2010; 22:889–91.

11. Elder RW, Parekh S, Book WM. More on hepatocellular carcinoma after the Fontan procedure. N Engl J Med. 2013; 369:490.

12. Youn JK, Lee JM, Yi NJ, Choi YR, Suh SW, You T, et al. Pediatric split liver transplantation after Fontan procedure in left isomerism combined with biliary atresia: a case report. Pediatr Transplant. 2014; 18:E274–9.

13. Cetta F, Feldt RH, O'Leary PW, Mair DD, Warnes CA, Driscoll DJ, et al. Improved early morbidity and mortality after Fontan operation: the Mayo Clinic experience, 1987 to 1992. J Am Coll Cardiol. 1996; 28:480–6.

14. Manzoni D, D'Ercole C, Spotti A, Carrara B, Sonzogni V. Congenital heart disease and pediatric liver transplantation: complications and outcome. Pediatr Transplant. 2007; 11:876–81.

15. Garbanzo JP, Kasahara M, Egawa H, Ikeda T, Doi H, Sakamoto S, et al. Results of living donor liver transplantation in five children with congenital cardiac malformations requiring cardiac surgery. Pediatr Transplant. 2006; 10:923–7.